In vitro hemocompatibility and toxic mechanism of graphene oxide on human peripheral blood T Lymphocytes and serum albumin

ACS Applied Materials and Interfaces

Volumn 6, Issue 22, 2014, Pages 19797-19807

  Ding, Zhijia ^a,b,c   Zhang, Zhijun ^a   Ma, Hongwei ^a   Chen, Yanyan ^a  

^a SUZHOU INSTITUTE OF NANO TECH AND NANO BIONICS   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Graphene oxide; Hemocompatibility; Plasma proteins; T lymphocytes; Toxic mechanism

Indexed keywords

BIOCOMPATIBILITY; BIOMEDICAL MATERIALS; BLOOD; CELL DEATH; GRAPHENE; GRAPHENE OXIDE; MEDICAL APPLICATIONS; PROTEINS; TOXICITY;

BINDING CAPACITIES; BIOMEDICAL APPLICATIONS; CONFORMATIONAL CHANGE; HEMOCOMPATIBILITY; HUMAN PERIPHERAL BLOOD; HUMAN SERUM ALBUMINS; PLASMA PROTEIN; SAFETY EVALUATIONS;

T-CELLS;

GRAPHITE; OXIDE; REACTIVE OXYGEN METABOLITE; SERUM ALBUMIN;

APOPTOSIS; CELL SURVIVAL; DNA DAMAGE; DRUG EFFECTS; HUMAN; METABOLISM; T LYMPHOCYTE;

APOPTOSIS; CELL SURVIVAL; DNA DAMAGE; GRAPHITE; HUMANS; OXIDES; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN; T-LYMPHOCYTES;

EID: 84914695553     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/am505084s     Document Type: Article

References (60)

1. Geim, A. K. Graphene: Status and Prospects. Science 2009, 324, 1530-1534.
2. Loh, K. P.; Bao, Q. L.; Eda, G.; Chhowalla, M. Graphene Oxide as a Chemically Tunable Platform for Optical Applications. Nat. Chem. 2010, 2, 1015-1024.
3. Wang, Y.; Li, Z. H.; Wang, J.; Li, J. H.; Lin, Y. H. Graphene and Graphene Oxide: Biofunctionalization and Applications in Biotechnology. Trends Biotechnol. 2011, 29, 205-212.
4. Singh, V.; Joung, D.; Zhai, L.; Das, S.; Khondaker, S. I.; Seal, S. Graphene based Materials: Past, Present and Future. Prog. Mater. Sci. 2011, 56, 1178-1271.
5. Sun, X. M.; Liu, Z.; Welsher, K.; Robinson, J. T.; Goodwin, A.; Zaric, S.; Dai, H. J. Nano-Graphene Oxide for Cellular Imaging and Drug Delivery. Nano Res. 2008, 1, 203-212.
6. Liu, Z.; Robinson, J. T.; Sun, X. M.; Dai, H. J. PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer Drugs. J. Am. Chem. Soc. 2008, 130, 10876-10877.
7. Yang, X. Y.; Zhang, X. Y.; Liu, Z. F.; Ma, Y. F.; Huang, Y.; Chen, Y. High-Efficiency Loading and Controlled Release of Doxorubicin Hydrochloride on Graphene Oxide. J. Phys. Chem. C 2008, 112, 17554-17558.
8. Zhang, L. M.; Xia, J. G.; Zhao, Q. H.; Liu, L. W.; Zhang, Z. J. Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer Drugs. Small 2010, 6, 537-544.
9. Ha, C. S.; Rana, V. K.; Choi, M. C.; Kong, J. Y.; Kim, G. Y.; Kim, M. J.; Kim, S. H.; Mishra, S.; Singh, R. P. Synthesis and Drug-Delivery Behavior of Chitosan-Functionalized Graphene Oxide Hybrid Nanosheets. Macromol. Mater. Eng. 2011, 296, 131-140.
10. Dong, H. F.; Ding, L.; Yan, F.; Ji, H. X.; Ju, H. X. The Use of Polyethylenimine-Grafted Graphene Nanoribbon for Cellular Delivery of Locked Nucleic Acid Modified Molecular Beacon for Recognition of MicroRNA. Biomaterials 2011, 32, 3875-3882.
11. Feng, L. Z.; Zhang, S. A.; Liu, Z. A. Graphene based Gene Transfection. Nanoscale 2011, 3, 1252-1257.
12. Zhang, L. M.; Lu, Z. X.; Zhao, Q. H.; Huang, J.; Shen, H.; Zhang, Z. J. Enhanced Chemotherapy Efficacy by Sequential Delivery of siRNA and Anticancer Drugs Using PEI-Grafted Graphene Oxide. Small 2011, 7, 460-464.
13. Bao, H. Q.; Pan, Y. Z.; Ping, Y.; Sahoo, N. G.; Wu, T. F.; Li, J.; Gan, L. H.; Li, L. Chitosan-Functionalized Graphene Oxide as a Nanocarrier for Drug and Gene Delivery. Small 2011, 7, 1569-1578.
14. Yang, K.; Zhang, S. A.; Zhang, G. X.; Sun, X. M.; Lee, S. T.; Liu, Z. A. Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal Therapy. Nano Lett. 2010, 10, 3318-3323.
15. Robinson, J. T.; Tabakman, S. M.; Liang, Y.; Wang, H.; Sanchez Casalongue, H.; Vinh, D.; Dai, H. Ultrasmall Reduced Graphene Oxide with High Near-Infrared Absorbance for Photothermal Therapy. J. Am. Chem. Soc. 2011, 133, 6825-6831.
16. Tian, B.; Wang, C.; Zhang, S.; Feng, L.; Liu, Z. Photothermally Enhanced Photodynamic Therapy Delivered by Nano-Graphene Oxide. ACS Nano 2011, 5, 7000-7009.
17. Yang, K.; Li, Y.; Tan, X.; Peng, R.; Liu, Z. Behavior and Toxicity of Graphene and its Functionalized Derivatives in Biological Systems. Small 2013, 9, 1492-1503.
18. Bianco, A. Graphene: Safe or Toxic? The Two Faces of the Medal. Angew. Chem., Int. Ed. 2013, 52, 4986-4997.
19. Seabra, A. B.; Paula, A. J.; de Lima, R.; Alves, O. L.; Duran, N. Nanotoxicity of Graphene and Graphene oxide. Chem. Res. Toxicol. 2014, 27, 159-168.
20. Wang, K.; Ruan, J.; Song, H.; Zhang, J. L.; Wo, Y.; Guo, S. W.; Cui, D. X. Biocompatibility of Graphene Oxide. Nanoscale Res. Lett. 2011, 6, 8.
21. Duch, M. C.; Budinger, G. R. S.; Liang, Y. T.; Soberanes, S.; Urich, D.; Chiarella, S. E.; Campochiaro, L. A.; Gonzalez, A.; Chandel, N. S.; Hersam, M. C.; Mutlu, G. M. Minimizing Oxidation and Stable Nanoscale Dispersion Improves the Biocompatibility of Graphene in the Lung. Nano Lett. 2011, 11, 5201-5207.
22. Zhang, X. Y.; Yin, J. L.; Peng, C.; Hu, W. Q.; Zhu, Z. Y.; Li, W. X.; Fan, C. H.; Huang, Q. Distribution and Biocompatibility Studies of Graphene Oxide in Mice after Intravenous Administration. Carbon 2011, 49, 986-995.
23. Vallabani, N. V. S.; Mittal, S.; Shukla, R. K.; Pandey, A. K.; Dhakate, S. R.; Pasricha, R.; Dhawan, A. Toxicity of Graphene in Normal Human Lung Cells (BEAS-2B). J. Biomed. Nanotechnol. 2011, 7, 106-107.
24. Yuan, J. F.; Gao, H. C.; Ching, C. B. Comparative Protein Profile of Human Hepatoma HepG2 Cells Treated with Graphene and Single-Walled Carbon Nanotubes: An iTRAQ-Coupled 2D LC-MS/MS Proteome Analysis. Toxicol. Lett. 2011, 207, 213-221.
25. Mullick Chowdhury, S.; Lalwani, G.; Zhang, K.; Yang, J. Y.; Neville, K.; Sitharaman, B. Cell Specific Cytotoxicity and Uptake of Graphene Nanoribbons. Biomaterials 2013, 34, 283-293.
26. Yue, H.; Wei, W.; Yue, Z.; Wang, B.; Luo, N.; Gao, Y.; Ma, D.; Ma, G.; Su, Z. The Role of the Lateral Dimension of Graphene Oxide in the Regulation of Cellular Responses. Biomaterials 2012, 33, 4013-4021.
27. Liao, K. H.; Lin, Y. S.; Macosko, C. W.; Haynes, C. L. Cytotoxicity of Graphene Oxide and Graphene in Human Erythrocytes and Skin Fibroblasts. ACS Appl. Mater. Interfaces 2011, 3, 2607-2615.
28. Chang, Y. L.; Yang, S. T.; Liu, J. H.; Dong, E.; Wang, Y. W.; Cao, A. N.; Liu, Y. F.; Wang, H. F. In Vitro Toxicity Evaluation of Graphene Oxide on A549 Cells. Toxicol. Lett. 2011, 200, 201-210.
29. Zhang, S. A.; Yang, K.; Feng, L. Z.; Liu, Z. In Vitro and in Vivo Behaviors of Dextran Functionalized Graphene. Carbon 2011, 49, 4040-4049.
30. Sasidharan, A.; Panchakarla, L. S.; Sadanandan, A. R.; Ashokan, A.; Chandran, P.; Girish, C. M.; Menon, D.; Nair, S. V.; Rao, C. N.; Koyakutty, M. Hemocompatibility and Macrophage Response of Pristine and Functionalized Graphene. Small 2012, 8, 1251-63.
31. Singh, S. K.; Singh, M. K.; Nayak, M. K.; Kumari, S.; Shrivastava, S.; Grácio, J. J. A.; Dash, D. Thrombus Inducing Property of Atomically Thin Graphene Oxide Sheets. ACS Nano 2011, 5, 4987-4996.
32. Singh, S. K.; Singh, M. K.; Kulkarni, P. P.; Sonkar, V. K.; Grácio, J. J.; Dash, D. Amine-Modified Graphene: Thrombo-Protective Safer Alternative to Graphene Oxide for Biomedical Applications. ACS Nano 2012, 6, 2731-2740.
33. Zhi, X.; Fang, H. L.; Bao, C. C.; Shen, G. X.; Zhang, J. L.; Wang, K.; Guo, S. W.; Wan, T.; Cui, D. X. The Immunotoxicity of Graphene Oxides and the Effect of PVP-Coating. Biomaterials 2013, 34, 5254-5261.
34. Zolnik, B. S.; González-Fernández, Á.; Sadrieh, N.; Dobrovolskaia, M. A. Minireview: Nanoparticles and the Immune System. Endocrinology 2010, 151, 458-465.
35. Tsoukas, C. D.; Landgraf, B.; Bentin, J.; Valentine, M.; Lotz, M.; Vaughan, J. H.; Carson, D. A. Activation of Resting T lymphocytes by Anti-CD3 (T3) Antibodies in the Absence of Monocytes. J. Immunol. 1985, 135, 1719-1723.
36. Fehske, K. J.; Muller, W. E.; Wollert, U. The Location of Drug-Binding Sites in Human-Serum Albumin. Biochem. Pharmacol. 1981, 30, 687-692.
37. Blauer, G.; Harmatz, D.; Naparste, A. Circular Dichroism of Bilirubin-Human Serum Albumin Complexes in Aqueous Solution. FEBS Lett. 1970, 9, 53-55.
38. Hummers, W. S.; Offeman, R. E. Preparation of Graphitic Oxide. J. Am. Chem. Soc. 1958, 80, 1339-1339.
39. Lai, Q.; Zhu, S.; Luo, X.; Zou, M.; Huang, S. Ultraviolet-Visible Spectroscopy of Graphene Oxides. AIP Adv. 2012, 2, 032146.
40. Mu, Q.; Su, G.; Li, L.; Gilbertson, B. O.; Yu, L. H.; Zhang, Q.; Sun, Y.-P.; Yan, B. Size-Dependent Cell Uptake of Protein-Coated Graphene Oxide Nanosheets. ACS Appl. Mater. Interfaces 2012, 4, 2259-2266.
41. Heiniger, H.-J.; Sodergren, A.; Marshall, J. D. Endocytosis in Cytotoxic T-Lymphocytes. Cell Immunol. 1981, 59, 429-434.
42. Hu, W. B.; Peng, C.; Luo, W. J.; Lv, M.; Li, X. M.; Li, D.; Huang, Q.; Fan, C. H. Graphene-Based Antibacterial Paper. ACS Nano 2010, 4, 4317-4323.
43. Akhavan, O.; Ghaderi, E. Toxicity of Graphene and Graphene Oxide Nanowalls Against Bacteria. ACS Nano 2010, 4, 5731-5736.
44. Sanchez, V. C.; Jachak, A.; Hurt, R. H.; Kane, A. B. Biological Interactions of Graphene-Family Nanomaterials: an Interdisciplinary Review. Chem. Res. Toxicol. 2011, 25, 15-34.
45. Agemy, L.; Sugahara, K. N.; Kotamraju, V. R.; Gujraty, K.; Girard, O. M.; Kono, Y.; Mattrey, R. F.; Park, J.-H.; Sailor, M. J.; Jimenez, A. I. Nanoparticle-Induced Vascular Blockade in Human Prostate Cancer. Blood 2010, 116, 2847-2856.
46. Lenardo, M.; Chan, F. K.-M.; Hornung, F.; McFarland, H.; Siegel, R.; Wang, J.; Zheng, L. Mature T lymphocyte Apoptosis-Immune Regulation in a Dynamic and Unpredictable Antigenic Environment 1. Annu. Rev. Immunol. 1999, 17, 221-253.
47. Strasser, A.; Harris, A.; Huang, D.; Krammer, P.; Cory, S. Bcl-2 and Fas/APO-1 Regulate Distinct Pathways to Lymphocyte Apoptosis. EMBO J. 1995, 14, 6136.
48. Hockenbery, D. M.; Oltvai, Z. N.; Yin, X.-M.; Milliman, C. L.; Korsmeyer, S. J. Bcl-2 Functions in an Antioxidant Pathway to Prevent Apoptosis. Cell 1993, 75, 241-251.
49. Kane, D. J.; Sarafian, T. A.; Anton, R.; Hahn, H.; Gralla, E. B.; Valentine, J. S.; Ord, T.; Bredesen, D. E. Bcl-2 Inhibition of Neural Death: Decreased Generation of Reactive Oxygen Species. Science 1993, 262, 1274-1277.
50. Jacobson, M. D.; Raff, M. C. Programmed Cell Death and Bcl-2 Protection in Very Low Oxygen. Nature 1995, 374, 814-816.
51. Jacobson, M. D. Reactive Oxygen Species and Programmed Cell Death. Trends Biochem. Sci. 1996, 21, 83-86.
52. Budinger, G. S.; Tso, M.; McClintock, D. S.; Dean, D. A.; Sznajder, J. I.; Chandel, N. S. Hyperoxia-Induced Apoptosis Does Not Require Mitochondrial Reactive Oxygen Species and Is Regulated by Bcl-2 Proteins. J. Biol. Chem. 2002, 277, 15654-15660.
53. Distelhorst, C. W.; Shore, G. C. Bcl-2 and Calcium: Controversy beneath the Surface. Oncogene 2004, 23, 2875-2880.
54. Antonsson, B.; Conti, F.; Ciavatta, A.; Montessuit, S.; Lewis, S.; Martinou, I.; Bernasconi, L.; Bernard, A.; Mermod, J.-J.; Mazzei, G. Inhibition of Bax Channel-Forming Activity by Bcl-2. Science 1997, 277, 370-372.
55. Penhale, W.; Farmer, A.; Maccuish, A.; Irvine, W. A Rapid Micro-Method for the Phytohaemagglutinin-Induced Human Lymphocyte Transformation Test. Clin. Exp. Immunol. 1974, 18, 155.
56. Hu, W. B.; Peng, C.; Lv, M.; Li, X. M.; Zhang, Y. J.; Chen, N.; Fan, C. H.; Huang, Q. Protein Corona-Mediated Mitigation of Cytotoxicity of Graphene Oxide. ACS Nano 2011, 5, 3693-3700.
57. Shen, M.; Wang, S. H.; Shi, X.; Chen, X.; Huang, Q.; Petersen, E. J.; Pinto, R. A.; Baker, J. R., Jr; Weber, W. J., Jr Polyethyleneimine-Mediated Functionalization of Multiwalled Carbon Nanotubes: Synthesis, Characterization, and In Vitro Toxicity Assay. J. Phys. Chem. C 2009, 113, 31.
58. Bhattacharjee, S.; de Haan, L. H.; Evers, N. M.; Jiang, X.; Marcelis, A. T.; Zuilhof, H.; Rietjens, I. M.; Alink, G. M. Role of Surface Charge and Oxidative Stress in Cytotoxicity of Organic Monolayer-Coated Silicon Nanoparticles towards Macrophage NR8383 Cells. Part. Fibre Toxicol. 2010, 7, 25-36.
59. Li, L. W.; Mu, Q. X.; Zhang, B.; Yan, B. Analytical Strategies for Detecting Nanoparticle-Protein Interactions. Analyst 2010, 135, 1519-1530.
60. Lacerda, S. H. D.; Park, J. J.; Meuse, C.; Pristinski, D.; Becker, M. L.; Karim, A.; Douglas, J. F. Interaction of Gold Nanoparticles with Common Human Blood Proteins. ACS Nano 2010, 4, 365-379.